Abstract:Objective: Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. The objective of this study was to evaluate the anticalcification effect of decellularization and detoxification in glutaraldehyde (GA)/genipin- and solvent-fixed bovine pericardium using a rabbit intramuscular model which is effective for assessing calcification in bioprosthetic tissue. Methods: Bovine pericardial tissues were fixed with 0.5% GA/0.4% genipin in organic solvent (75% ethanol + 5% octanol, 75% ethanol + 5% octanediol, or 70% ethanol + 10% isopropanol) and post-treated with glycine, glutamic acid, or sodium bisulfite. Decellularization was performed with 0.25% sodium dodecylsulfate prior to fixation. The material characteristics of the treated tissues were assessed by thermal stability test, uniaxial mechanical test, and light microscopy. Stability of the treated tissue was measured by the resistance to enzymatic degradation using protease. The tissues were intramuscularly implanted into 4-week-old rabbits for 8 weeks, and the anti-α-Gal(Gal[alpha]1,3-Gal[beta]1,4GlcNAc-R) antibodies (immunoglobulin G) were measured at various time intervals after implantation. Explanted tissues were examined by light microscopy and calcium contents of the explanted tissues were measured. Results: Differently treated tissues resulted in no significant alterations in material characteristics and morphology. GA groups are superior to genipin groups in tissue cross-linking without difference according to addition of decellularization, organic solvent treatment, and detoxification by resistance toward pronase degradation. The titer of anti-α-Gal antibodies gradually increased after implantation in all study groups. The titer of anti-α-Gal antibodies increased less in genipin groups than in GA groups, and less with decellularization than without decellularization. The calcium contents of genipin groups (n = 75) were significantly lower than those of GA groups (n = 118) (28.55 ± 11.22 μg mg(-1) vs 37.16 ± 7.75 μg mg(-1), p < 0.001). Calcium contents decreased with decellularization, organic solvent treatment, and detoxification, irrespective of the type of organic solvent and amino acids. Inorganic phosphorus contents of genipin groups (n = 66) were significantly lower than those of GA groups (n = 103) (55.36 ± 26.98 μg mg(-1) vs 75.67 ± 23.44 μg mg(-1), p = 0.000). Conclusions: Genipin fixation is a novel alternative to conventional GA fixation in vitro material assessment and in vivo anticalcification effect. The addition of decellularization, organic solvent treatment, and detoxification prevented calcification of GA/genipin-fixed bovine pericardium in the rabbit intramuscular implantation model, irrespective of the type of organic solvent and amino acids.

Is Autologous or Heterologous Pericardium Better for Valvuloplasty? A Comparative Study of Calcification Propensity

Tissue-engineered and autologous pericardium in congenital heart surgery: comparative histopathological study of human vascular explants

Comparison on the Properties of Bovine Pericardium and Porcine Pericardium Used As Leaflet Materials of Transcatheter Heart Valve.

Implantation of recellularized pericardial fibrous scaffold in vivo:a one-year animal study

Tissue requirements for the application of aortic valve neocuspidization – appropriate pericardium properties and homogeneity?

Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium

Donkey Pericardium As a Select Sourcing to Manufacture Percutaneous Heart Valves: Decellularization Has Not Yet Demonstrated Any Clear Cut Advantage to Glutaraldehyde Treatment

Prevention of Tissue Calcification on Bioprosthetic Heart Valve by Using Epoxy Compounds: a Study of Calcification Tests in Vitro and in Vivo.

Nonglutaraldehyde Fixation for off the Shelf Decellularized Bovine Pericardium in Anticalcification Cardiac Valve Applications

Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves

0.1 Mm Eptfe Versus Autologous Pericardium for Hand-Sewn Trileaflet Valved Conduit: a Comparative Study

Bioprosthetic Heart Valves’ Structural Integrity Improvement Through Exogenous Amino Donor Treatments

In vivo application of a glutaraldehyde-free, UVA/riboflavin cross-linked bovine pericardium confirms suitability for cardiovascular substitutes

Arginine-grafted porcine pericardium by copolymerization to improve the cytocompatibility, hemocompatibility and anti-calcification properties of bioprosthetic heart valve materials

Gal knockout pig pericardium: new source of material for heart valve bioprostheses

Histological examination of explanted tissue-engineered bovine pericardium following heart valve repair

The Study of Dry Biological Valve Crosslinked with a Combination of Carbodiimide and Polyphenol

Nonglutaraldehyde Crosslinked Bioprosthetic Heart Valves Based on 2-Isocyanatoethyl Methacrylate Crosslinked Porcine Pericardium with Improved Properties of Stability, Cytocompatibility and Anti-Calcification

A Comparative Study Between Porcine Peritoneum and Pericardium As Cardiovascular Material.

Experiment of autogenous pericardlal conduit as substitute for coronary artery bypass

Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves